nDash.com is a content creation platform that provides brands and agencies with access to the world's top freelance writers.

Idea from John Heinz

Title

Demand Generation Content Marketing: Targeted Industries - Pharmaceutical Regulatory Compliance News Item Focus

Summary

In April 2021, President Biden signed two bipartisan bills that aim to promote drug competition and to reduce prescription drug prices—the Ensuring Innovation Act (EIA)1 and the Advancing Education on Biosimilars Act of 2021 (Biosimilars Act). The successful passage of each of these laws could impact pharmaceutical quality assurance and management approaches. This article will outline what is being debated and why these pieces of legislation are important for manufacturers to be aware of.

Author

John Heinz

Keywords

  • pharmaceutical industry
  • regulatory compliance
  • federal regulations
  • quality assurance
  • quality management systems
  • Links

  • https://www.jdsupra.com/legalnews/biden-administration-inks-bills-to-6848575/